Domain Due Diligence
Report for Pharmeasy.in
Why we think so
PharmEasy.in is an established online pharmacy based primarily in India, drawing about 8.4 million visits monthly with a strong direct and search-driven user base. It operates a robust technology and advertising infrastructure, including Amazon hosting, Google Analytics, and multiple advertising partners. Contact information is publicly available via its own website and verified social media channels. PharmEasy holds a valid SSL certificate and stable DNS settings. However, independent consumer reviews reveal persistent issues, including complaints about delivery delays, refund problems, expired medicines, and poor customer support. The platform was fined ₹2 lakh by Indian consumer authorities in 2024 for unfair subscription auto-renewal practices. Financial reports indicate some fiscal stress, notably breach of a loan covenant with Goldman Sachs. Overall, PharmEasy is a recognized service with significant market presence but exhibits notable consumer service challenges and regulatory concerns. Use with caution, verifying medicines on receipt and preferring secure payment and clear communication channels.
Risk Insights
High consumer complaint volume
Established technical infrastructure
Contradictory Signals
While PharmEasy operates as a technically legitimate platform, user experience and regulatory compliance issues contradict full trustworthiness.
Signal A: Legitimate technical infrastructure and high traffic
Signal B: Widespread negative consumer reviews and regulatory fines
Category Scores
Red Flags & Warnings
-
Multiple verified complaints about expired medicines and refusal of refunds raise concerns about product quality and customer service.
-
Indian consumer regulator fined PharmEasy for unfair subscription auto-renewal, highlighting compliance risks.
-
Reports of delivery fraud and false 'delivered' statuses indicate operational and trust-worthiness issues.
🔎 Detailed Checks & Analysis
Domain legitimacy via technology and hosting
Domain legitimacy via technology and hosting
"The domain resolves reliably with stable DNS and includes recognized analytics and CDN tools."
Reason: PharmEasy uses reputable AWS hosting, valid SSL cert, and standard technologies confirming domain authenticity.
Traffic volume and geography
Traffic volume and geography
"Bounce rate and visit stats are consistent with a popular service."
Reason: Site receives about 8.4 million monthly visits, mainly from India, confirming significant legitimate user engagement.
Public contact transparency
Public contact transparency
"Supports consumer ability to contact and verify the business."
Reason: Multiple email addresses, phone numbers, and verified social media links are openly published.
Blacklist and phishing detection
Blacklist and phishing detection
"Domain is not reported for phishing or crypto fraud."
Reason: No flags or detected threats on Google Safe Browsing or crypto scam blacklists.
Consumer complaint and reputation analysis
Consumer complaint and reputation analysis
"Mixed reviews with critical safety concerns on independent platforms."
Reason: Serious and repeated reports of expired medicines, delivery failures, and refund issues reduce trust.
Legal and regulatory compliance
Legal and regulatory compliance
"Financial stress and lender disputes noted but not directly impacting consumer protection currently."
Reason: A recent CCPA fine for unfair auto-renewal subscriptions signals regulatory risk.
Your Next Steps
-
1If you intend to use PharmEasy, always check expiry dates on delivered products before acceptance.
-
2Avoid relying on PharmEasy for urgent or critical medicine needs due to reported delivery inconsistencies.
-
3Use payment methods that provide consumer protection and document all transactions and communications.
-
4Monitor news and regulatory updates regarding PharmEasy for potential changes in service quality or legal status.
-
5Consider customer feedback platforms for ongoing reputation insights before making purchases.
Evidence & Citations
-
PharmEasy reviews and consumer complaints – PissedConsumer
Consumer reports reveal issues with expired medicines, refunds, and delivery.
-
Central Consumer Protection Authority fines PharmaEasy for auto-renewal subscriptions
Regulatory penalty highlights unfair subscription practices in late 2023 and mid 2024.
-
PharmEasy detailed technology profile – SimilarTech
Technical infrastructure and traffic details indicating legitimate domain operation.
-
PharmEasy financial and regulatory news – Economic Times
Reports of financial stress related to equity raising failures.
🕵🏻 Keep investigating
Run another instant due diligence scan on any website URL. Verify before you trust!
High-pressure funnels promise impossible APYs and embed unlicensed wallets or merchant IDs. ScamAI dissects the hosting...
Read playbook →Landing pages promise cracked software or video codecs but actually drop stealers and remote access trojans. ScamAI fing...
Read playbook →